Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-85.7%-12.0pp-73.7%+21.7pp-95.4%+12.2pp-107.6%-23.5pp-84%+15.5pp
Return on assets-59.7%-7.7pp-52%+20.7pp-72.7%+7.9pp-80.6%-9.7pp-70.9%+8.9pp
Return on invested capital-147.2%-17.9pp-129.2%+0.8pp-130%+23.2pp-153.2%+19.0pp-172.1%-33.8pp
Liquidity
Current ratio15.1×+0.9×14.2×+7.9×6.4×+2.2×4.2×-0.9×5.1×-0.2×
Quick ratio15.1×+0.9×14.2×+7.9×6.4×+2.2×4.2×-0.9×5.1×-0.2×
Cash ratio4.2×-0.7×4.9×+2.9×-0.2×2.2×-0.4×2.6×+0.8×
Leverage
Debt-to-equity0.0×-0.2×0.2×-0.2×0.4×+0.3×0.1×0.0×
Debt-to-assets0.0×-0.1×0.1×-0.1×0.2×+0.2×0.1×0.0×
Interest coverage-84.7×+24.2×-108.9×
Per Share
Book value per share$3.75-24.1%$4.94+125%$2.20+62.4%$1.35-29.9%$1.93-21.7%
Valuation
Market capitalization$6.25B+14.6%$5.45B+172%$2.01B+143%$824.32M+20.9%$681.96M-20.8%
Enterprise value$6.02B+16.8%$5.16B+166%$1.94B+156%$757.38M+32.2%$573.05M-26.6%
Price / book10.3×+1.7×8.6×+1.9×6.6×+1.3×5.3×+2.2×3.1×-0.2×
Free cash flow yield-4.6%+0.3pp-4.9%+7.4pp-12.3%+16.2pp-28.5%+4.2pp-32.7%-8.5pp
Earnings yield-5.7%+0.4pp-6%+8.6pp-14.7%+19.8pp-34.5%+5.1pp-39.5%-9.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Cogent Biosciences, Inc.'s ratios come from?
Every ratio is computed from Cogent Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.